GLP1 Guide

GLP1 Guide

❤️ Semaglutide beats Tirzepatide for Heart Health

A win for Novo Nordisk and patients everywhere, but the study does have caveats.

Sep 09, 2025
∙ Paid

While Mounjaro/Zepbound (Tirzepatide) is the most effective GLP1 when it comes to weight management:

📑 Tirzepatide vs Semaglutide, in a Trial

📑 Tirzepatide vs Semaglutide, in a Trial

GLP1 Guide
·
June 9, 2025
Read full story

But recent research had made it clear that Ozempic/Wegovy (Semaglutide) is better than Mounjaro/Zepbound (Tirzepatide) when it comes to improving outcomes related to heart health.

To be clear, both medications are amazing and do things that most would not have thought possible just a short while ago, but the data helps everyone guide intuition.

Many news sources have already covered the data, but we took the time to go deeper and read more of the actual study to see what others may have missed.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 GLP1 Guide · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture